Constitutively Active BRS3 is a Genuinely Orphan GPCR in Placental Mammals

Overview

Journal PLoS Biol

Specialty Biology

Date 2019 Mar 7

PMID 30840614

Citations 5

Authors

Huihao Tang

Chuanjun Shu

Haidi Chen

Xiaojing Zhang

Zhuqing Zang

Cheng Deng

Affiliations

Soon will be listed here.

Abstract

G protein-coupled receptors (GPCRs) play an important role in physiology and disease and represent the most productive drug targets. Orphan GPCRs, with their endogenous ligands unknown, were considered a source of drug targets and consequently attract great interest to identify their endogenous cognate ligands for deorphanization. However, a contrary view to the ubiquitous existence of endogenous ligands for every GPCR is that there might be a significant overlooked fraction of orphan GPCRs that function constitutively in a ligand-independent manner only. Here, we investigated the evolution of the bombesin receptor-ligand family in vertebrates in which one member-bombesin receptor subtype-3 (BRS3)-is a potential orphan GPCR. With analysis of 17 vertebrate BRS3 structures and 10 vertebrate BRS3 functional data, our results demonstrated that nonplacental vertebrate BRS3 still connects to the original ligands-neuromedin B (NMB) and gastrin-releasing peptide (GRP)-because of adaptive evolution, with significantly changed protein structure, especially in three altered key residues (Q127R, P205S, and R294H) originally involved in ligand binding/activation, whereas the placental mammalian BRS3 lost the binding affinity to NMB/GRP and constitutively activates Gs/Gq/G12 signaling in a ligand-independent manner. Moreover, the N terminus of placental mammalian BRS3 underwent positive selection, exhibiting significant structural differences compared to nonplacental vertebrate BRS3, and this domain plays an important role in constitutive activity of placental mammalian BRS3. In conclusion, constitutively active BRS3 is a genuinely orphan GPCR in placental mammals, including human. To our knowledge, this study identified the first example that might represent a new group of genuinely orphan GPCRs that will never be deorphanized by the discovery of a natural ligand and provided new perspectives in addition to the current ligand-driven GPCR deorphanization.

Citing Articles

GPR15-C10ORF99 functional pairing initiates colonic Treg homing in amniotes.

Song J, Zheng H, Xue J, Liu J, Sun Q, Yang W EMBO Rep. 2021; 23(3):e53246.

PMID: 34939731 PMC: 8892231. DOI: 10.15252/embr.202153246.

The gastrin-releasing peptide/bombesin system revisited by a reverse-evolutionary study considering Xenopus.

Hirooka A, Hamada M, Fujiyama D, Takanami K, Kobayashi Y, Oti T Sci Rep. 2021; 11(1):13315.

PMID: 34172791 PMC: 8233351. DOI: 10.1038/s41598-021-92528-x.

The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases.

Coleman J, Ngo T, Smythe R, Cleave A, Jones N, Graham R Sci Rep. 2020; 10(1):19995.

PMID: 33203955 PMC: 7673139. DOI: 10.1038/s41598-020-76384-9.

BRS3 in both MC4R- and SIM1-expressing neurons regulates energy homeostasis in mice.

Xiao C, Liu N, Province H, Pinol R, Gavrilova O, Reitman M Mol Metab. 2020; 36:100969.

PMID: 32229422 PMC: 7113433. DOI: 10.1016/j.molmet.2020.02.012.

Novel approaches leading towards peptide GPCR de-orphanisation.

Hauser A, Gloriam D, Brauner-Osborne H, Foster S Br J Pharmacol. 2019; 177(5):961-968.

PMID: 31863461 PMC: 7042120. DOI: 10.1111/bph.14950.

References

Tang X, Wang Y, Li D, Luo J, Liu M . Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets. Acta Pharmacol Sin. 2012; 33(3):363-71. PMC: 4077139. DOI: 10.1038/aps.2011.210. View

Fang Y, Kenakin T, Liu C . Editorial: Orphan GPCRs As Emerging Drug Targets. Front Pharmacol. 2015; 6:295. PMC: 4678218. DOI: 10.3389/fphar.2015.00295. View

Chou P, Fasman G . Prediction of protein conformation. Biochemistry. 1974; 13(2):222-45. DOI: 10.1021/bi00699a002. View

Meyer R, Giddens M, Schaefer S, Hall R . GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc Natl Acad Sci U S A. 2013; 110(23):9529-34. PMC: 3677493. DOI: 10.1073/pnas.1219004110. View

Guan X, Chen H, Dobbelaar P, Dong Y, Fong T, Gagen K . Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity. Cell Metab. 2010; 11(2):101-12. DOI: 10.1016/j.cmet.2009.12.008. View

Ngo T, Kufareva I, Coleman J, Graham R, Abagyan R, Smith N . Identifying ligands at orphan GPCRs: current status using structure-based approaches. Br J Pharmacol. 2016; 173(20):2934-51. PMC: 5341249. DOI: 10.1111/bph.13452. View

Boyle R, Humphries J, Mitchell T, Showell G, Apaya R, Iijima H . The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3). J Pept Sci. 2005; 11(3):136-41. DOI: 10.1002/psc.599. View

Kroog G, Jensen R, Battey J . Mammalian bombesin receptors. Med Res Rev. 1995; 15(5):389-417. DOI: 10.1002/med.2610150502. View

Thomsen W, Frazer J, Unett D . Functional assays for screening GPCR targets. Curr Opin Biotechnol. 2005; 16(6):655-65. DOI: 10.1016/j.copbio.2005.10.008. View

10.

London N, Raveh B, Cohen E, Fathi G, Schueler-Furman O . Rosetta FlexPepDock web server--high resolution modeling of peptide-protein interactions. Nucleic Acids Res. 2011; 39(Web Server issue):W249-53. PMC: 3125795. DOI: 10.1093/nar/gkr431. View

11.

Chalmers D, Behan D . The use of constitutively active GPCRs in drug discovery and functional genomics. Nat Rev Drug Discov. 2002; 1(8):599-608. DOI: 10.1038/nrd872. View

12.

Deng C, Chen H, Yang N, Feng Y, Hsueh A . Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling. J Biol Chem. 2015; 290(30):18261-8. PMC: 4513087. DOI: 10.1074/jbc.M115.648238. View

13.

Nishimura A, Kitano K, Takasaki J, Taniguchi M, Mizuno N, Tago K . Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule. Proc Natl Acad Sci U S A. 2010; 107(31):13666-71. PMC: 2922266. DOI: 10.1073/pnas.1003553107. View

14.

Gbahou F, Holst B, Schwartz T . Molecular basis for agonism in the BB3 receptor: an epitope located on the interface of transmembrane-III, -VI, and -VII. J Pharmacol Exp Ther. 2010; 333(1):51-9. DOI: 10.1124/jpet.109.162131. View

15.

Berger B, Acebron S, Herbst J, Koch S, Niehrs C . Parkinson's disease-associated receptor GPR37 is an ER chaperone for LRP6. EMBO Rep. 2017; 18(5):712-725. PMC: 5412897. DOI: 10.15252/embr.201643585. View

16.

Ohki-Hamazaki H, Iwabuchi M, Maekawa F . Development and function of bombesin-like peptides and their receptors. Int J Dev Biol. 2005; 49(2-3):293-300. DOI: 10.1387/ijdb.041954ho. View

17.

Xiao C, Pinol R, Carlin J, Li C, Deng C, Gavrilova O . Bombesin-like receptor 3 (Brs3) expression in glutamatergic, but not GABAergic, neurons is required for regulation of energy metabolism. Mol Metab. 2017; 6(11):1540-1550. PMC: 5681273. DOI: 10.1016/j.molmet.2017.08.013. View

18.

Tao Y . Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics. Pharmacol Ther. 2008; 120(2):129-48. PMC: 2668812. DOI: 10.1016/j.pharmthera.2008.07.005. View

19.

Nakagawa T, Hocart S, Schumann M, Tapia J, Mantey S, Coy D . Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP). Biochem Pharmacol. 2005; 69(4):579-93. DOI: 10.1016/j.bcp.2004.11.003. View

20.

Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W . Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun. 2006; 351(1):21-5. DOI: 10.1016/j.bbrc.2006.09.141. View